JANX JANUX THERAPEUTICS INC Other Situations 8-K Filing 2024 - Capital Resources and Interim Clinical Data Update Janux Therapeutics, Inc. provides an update on its capital resources and reports interim clinical data for its PSMA-TRACTr and EGFR-TRACTr programs.Get access to all SEC 8-K filings of the JANUX THERAPEUTICS INC